PTEN and central nervous system cancer: Transcriptome analyses of PTEN-null H4 glioma cells, in which either the wild-type PTEN or a methylation-defective (R159) mutant were overexpressed, uncovered massive AS dysregulation as a consequence of the constitutive activation of the PI3K/AKT signaling pathway in the PTEN mutant cells [145].